Format

Send to

Choose Destination
Virulence. 2012 Nov 15;3(7):592-4. doi: 10.4161/viru.22364. Epub 2012 Nov 15.

Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics.

Author information

1
Department of Molecular Microbiology and Center for Womens' Infectious Disease Research, Washington University in St. Louis, St. Louis, MO, USA.

KEYWORDS:

alternative therapeutics; mannosides; two-component systems; type 1 pili; urinary tract infection; uropathogenesis; virulence gene regulation

PMID:
23154288
PMCID:
PMC3545937
DOI:
10.4161/viru.22364
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center